KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Change in Accured Expenses (2016 - 2025)

Cme (CME) has disclosed Change in Accured Expenses for 17 consecutive years, with -$27.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 29.69% to -$27.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$34.6 million, a 37.55% increase, with the full-year FY2025 number at -$34.6 million, up 37.55% from a year prior.
  • Change in Accured Expenses was -$27.0 million for Q4 2025 at Cme, down from $1.6 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $701.4 million in Q3 2024 to a low of -$716.6 million in Q2 2024.
  • A 5-year average of -$11.7 million and a median of -$10.7 million in 2021 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: surged 6044.07% in 2024, then tumbled 3072.22% in 2025.
  • Cme's Change in Accured Expenses stood at -$17.9 million in 2021, then surged by 63.13% to -$6.6 million in 2022, then surged by 127.27% to $1.8 million in 2023, then plummeted by 2233.33% to -$38.4 million in 2024, then rose by 29.69% to -$27.0 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Change in Accured Expenses are -$27.0 million (Q4 2025), $1.6 million (Q3 2025), and $47.9 million (Q2 2025).